KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vir Biotechnology (VIR) EPS (Basic) (2018 - 2025)

Historic EPS (Basic) for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$1.17.

  • Vir Biotechnology's EPS (Basic) rose 2500.0% to -$1.17 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.61, marking a year-over-year increase of 790.82%. This contributed to the annual value of -$3.83 for FY2024, which is 1653.62% up from last year.
  • According to the latest figures from Q3 2025, Vir Biotechnology's EPS (Basic) is -$1.17, which was up 2500.0% from -$0.8 recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's EPS (Basic) ranged from a high of $4.04 in Q4 2021 and a low of -$1.56 during Q3 2024
  • Moreover, its 5-year median value for EPS (Basic) was -$0.8 (2025), whereas its average is -$0.17.
  • As far as peak fluctuations go, Vir Biotechnology's EPS (Basic) skyrocketed by 51220.69% in 2021, and later tumbled by 22083.33% in 2022.
  • Vir Biotechnology's EPS (Basic) (Quarter) stood at $4.04 in 2021, then plummeted by 119.06% to -$0.77 in 2022, then dropped by 11.69% to -$0.86 in 2023, then grew by 10.74% to -$0.77 in 2024, then tumbled by 52.41% to -$1.17 in 2025.
  • Its EPS (Basic) was -$1.17 in Q3 2025, compared to -$0.8 in Q2 2025 and -$0.88 in Q1 2025.